[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.52.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
March 2018

Association of Breast Implants With Anaplastic Large-Cell Lymphoma

Author Affiliations
  • 1Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
  • 2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
JAMA Oncol. 2018;4(3):341-342. doi:10.1001/jamaoncol.2017.4467

Although our understanding of the association between breast implants and anaplastic large-cell lymphoma (ALCL) has increased since the first published case report in 1997,1 questions about this unique clinicopathological entity still outnumber the answers. What causes breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)? Who is at risk? How great is the risk? What is the optimal treatment?

×